⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL652435 | 0.89 | — | — | |
| SCHEMBL29084246 | 0.86 | DNM1 (0.53) | — | |
| SCHEMBL6955775 | 0.86 | DNM1 (0.53) | — | |
| SCHEMBL6609179 | 0.86 | — | — | |
| SCHEMBL654031 | 0.86 | — | — | |
| SCHEMBL3495284 | 0.79 | — | — | |
| SCHEMBL5308073 | 0.79 | — | — | |
| SCHEMBL94135 | 0.75 | — | — | |
| SCHEMBL5300768 | 0.75 | — | — | |
| SCHEMBL5304496 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 123 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2200440-B1 | ANTIBACTERIAL AMIDE AND SULFONAMIDE SUBSTITUTED HETEROCYCLIC UREA COMPOUNDS | CRESTONE INC (US) | 2017-07-19 | — | — | EP | claimed |
| US-20170082642-A1 | FLUORESCENT CELL MARKERS | KODE BIOTECH LTD (NZ) | 2017-03-23 | — | — | US | claimed |
| EP-2069460-B1 | FLUORESCENT CELL MARKERS | KODE BIOTECH LTD (NZ) | 2013-10-16 | — | — | EP | claimed |
| EP-1871823-B1 | POLYMER CAPSULE AND PROCESS FOR THE PREPARATION THEREOF | POSTECH FOUNDATION (KR) | 2013-03-27 | — | — | EP | claimed |
| US-20120148670-A1 | SENSITIVE POLYMER CAPSULE AND METHOD OF MANUFACTURING THE SAME | POSTECH ACADEMAY-INDUSTRY FOUNDATION (KR) | 2012-06-14 | — | — | US | claimed |
| US-8148380-B2 | Antibacterial amide and sulfonamide substituted heterocyclic urea compounds | CRESTONE, INC. (US) | 2012-04-03 | — | — | US | claimed |
| US-20120015941-A1 | Antibacterial Amide and Sulfonamide Substituted Heterocyclic Urea Compounds | CRESTONE, INC. (US) | 2012-01-19 | — | — | US | claimed |
| US-20100203637-A1 | Fluorescent cell markers | KODE BIOTECH LIMITED (NZ) | 2010-08-12 | — | — | US | claimed |
| CN-101679849-A | Fluorescent cell markers | ELENA KORCHAGINA | 2010-03-24 | — | — | CN | claimed |
| EP-2069460-A2 | FLUORESCENT CELL MARKERS | Korchagina, Elena (RU) | 2009-06-17 | — | — | EP | claimed |
| US-20080175920-A1 | Polymer Capsule and Process For the Preparation Thereof | POSTECH FOUNDATION (KR) | 2008-07-24 | — | — | US | claimed |
| WO-2008030115-A2 | FLUORESCENT CELL MARKERS | KORCHAGINA ELENA (RU) | 2008-03-13 | — | — | WO | claimed |
| US-20070212404-A1 | Liposome And Method Of Preparing The Same | POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) | 2007-09-13 | — | — | US | claimed |
| WO-2005112890-A1 | LIPOSOME AND METHOD OF PREPARING THE SAME | POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) | 2005-12-01 | — | — | WO | claimed |
| US-6391913-B1 | ANTICANCER AGENTS | BCM DEVELOPMENT INC. (CA) | 2002-05-21 | — | — | US | claimed |
| US-11939408-B2 | Hyaluronic acid derivatives | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2024-03-26 | — | — | US | disclosed |
| US-20230104311-A1 | NOVEL 6-SUBSTITUTED 7-DEAZAPURINES AND CORRESPONDING NUCLEOSIDES AS MEDICAMENTS | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2023-04-06 | — | — | US | disclosed |
| US-5430132-A | Semi-synthetic glycosaminoglycans containing α-L-galacturonic acid substituted with nucleophilic groups in position 3 | ALFA WASSERMANN S.P.A. (IT) | 1995-07-04 | — | — | US | disclosed |
| EP-0565862-A2 | Semi-synthetic glycosaminoglycans containing alpha-L-galacturonic acid substituted with nucleophilic radicals in position 3 | ALFA WASSERMANN S.p.A. (IT) | 1993-10-20 | — | — | EP | disclosed |
| US-3976762-A | RADIOACTIVE DRUGS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1976-08-24 | — | — | US | disclosed |